Early-Stage Researcher

Partner Lab

Novo Nordisk is a global healthcare company with unique competencies in chemical and protein engineering, which drive the design of new treatments that address the unmet needs of people living with chronic diseases like diabetes, haemophilia and growth disorders.


Yara Huppelschoten obtained her Bachelor´s degree in Chemistry at the Hogeschool Leiden, the Netherlands. During her bachelor, she performed a 9-month internship at the laboratory of Prof. Huib Ovaa at The Netherlands Cancer Institute. She worked on a variety of projects such as the synthesis of small molecules, chemical libraries and chemical probes. She also studied a minor in biopharmaceutical analysis, which got her interested in more than organic chemistry.

She therefore started a Master in Molecular Pharmacology at the Vrije Universiteit Amsterdam. She performed a 7-month internship at the laboratory of Prof. Rob Leurs, where she mainly focused on the pharmacological characterization of photoswitchable ligands for the histamine 3 receptor. Yara obtained her Master’s degree in August 2018, and moved to Copenhagen to pursue her PhD at Novo Nordisk.